Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related AKBA
Netflix Goes 7-For-1; Vanda Pharma And FibroGen Lead Tuesday's After-Hours Movers
Benzinga's Top Initiations
After Hours Gainers / Losers (Seeking Alpha)
Related AI
Top 4 Small-Cap Stocks In The Mortgage Investment Industry With The Highest EPS Growth Forecast For Next 5 Years
Is Sallie Mae (SLM) Likely to Miss Earnings This Season?
Mortgage REITs remain under pressure even as rates fall (Seeking Alpha)

Analysts at Nomura initiated coverage on shares of Akebia Therapeutics (NASDAQ: AKBA) with a “buy” rating. The target price for Akebia Therapeutics is set to $39. Akebia Therapeutics' shares closed at $16.86 on Friday.

Credit Suisse initiated coverage on shares of Arlington Asset Investment (NYSE: AI) with a “neutral” rating. The target price for Arlington Asset Investment is set to $26. Arlington Asset Investment's shares closed at $25.65 on Friday.

SunTrust Robinson Humphrey initiated coverage on shares of Pandora Media (NYSE: P) with a “buy” rating. The target price for Pandora Media is set to $34. Pandora's shares closed at $25.31 on Friday.

Analysts at Stifel Nicolaus initiated coverage on shares of Q2 Holdings (NYSE: QTWO) with a “buy” rating. The target price for Q2 Holdings is set to $18. Q2 Holdings' shares closed at $13.68 on Friday.

Latest Ratings for AKBA

DateFirmActionFromTo
Jun 2015JMP SecuritiesInitiates Coverage onOutperform
May 2015Brean CapitalInitiates Coverage onBuy
May 2015NeedhamInitiates Coverage onBuy

View More Analyst Ratings for AKBA
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (AI + AKBA)

Around the Web, We're Loving...

Get Benzinga's Newsletters